Global Microbiome Drugs Market Size, Status and Forecast 2022

Published: Nov, 2017 | Pages: 90 | Publisher: QYResearch
Industry: ICT | Report Format: Electronic (PDF)

This report studies the global Microbiome Drugs market, analyzes and researches the Microbiome Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
    Pfizer
    Second Genome
    Seres Therapeutics
    MaaT Pharma
    Enterome Bioscience
    MicroBiome Therapeutics
    Ritter Pharmaceuticals
    Rebiotix
    OpenBiome

Market segment by Regions/Countries, this report covers
    United States
    EU
    Japan
    China
    India
    Southeast Asia

Market segment by Type, the product can be split into
    Probiotics
    Prebiotics
    Small Molecules
    Biological Drugs
    Other

Market segment by Application, Microbiome Drugs can be split into
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 Table of Contents

Global Microbiome Drugs Market Size, Status and Forecast 2022
1 Industry Overview of Microbiome Drugs
    1.1  Microbiome Drugs Market Overview
        1.1.1 Microbiome Drugs Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Microbiome Drugs Market Size and Analysis by Regions
        1.2.1 United States
        1.2.2 EU
        1.2.3 Japan
        1.2.4 China
        1.2.5 India
        1.2.6 Southeast Asia
    1.3 Microbiome Drugs Market by Type
        1.3.1 Probiotics
        1.3.2 Prebiotics
        1.3.3 Small Molecules
        1.3.4 Biological Drugs
        1.3.5 Other
    1.4 Microbiome Drugs Market by End Users/Application
        1.4.1 Hospital Pharmacies
        1.4.2 Retail Pharmacies
        1.4.3 Online Pharmacies
        1.4.4 Other

2 Global Microbiome Drugs Competition Analysis by Players
    2.1 Microbiome Drugs Market Size (Value) by Players (2016 and 2017)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 Pfizer
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Microbiome Drugs Revenue (Value) (2012-2017)
        3.1.5 Recent Developments
    3.2 Second Genome
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Microbiome Drugs Revenue (Value) (2012-2017)
        3.2.5 Recent Developments
    3.3 Seres Therapeutics
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Microbiome Drugs Revenue (Value) (2012-2017)
        3.3.5 Recent Developments
    3.4 MaaT Pharma
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Microbiome Drugs Revenue (Value) (2012-2017)
        3.4.5 Recent Developments
    3.5 Enterome Bioscience
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Microbiome Drugs Revenue (Value) (2012-2017)
        3.5.5 Recent Developments
    3.6 MicroBiome Therapeutics
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Microbiome Drugs Revenue (Value) (2012-2017)
        3.6.5 Recent Developments
    3.7 Ritter Pharmaceuticals
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Microbiome Drugs Revenue (Value) (2012-2017)
        3.7.5 Recent Developments
    3.8 Rebiotix
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Microbiome Drugs Revenue (Value) (2012-2017)
        3.8.5 Recent Developments
    3.9 OpenBiome
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Microbiome Drugs Revenue (Value) (2012-2017)
        3.9.5 Recent Developments

4 Global Microbiome Drugs Market Size by Type and Application (2012-2017)
    4.1 Global Microbiome Drugs Market Size by Type (2012-2017)
    4.2 Global Microbiome Drugs Market Size by Application (2012-2017)
    4.3 Potential Application of Microbiome Drugs in Future
    4.4 Top Consumer/End Users of Microbiome Drugs

5 United States Microbiome Drugs Development Status and Outlook
    5.1 United States Microbiome Drugs Market Size (2012-2017)
    5.2 United States Microbiome Drugs Market Size and Market Share by Players (2016 and 2017)

6 EU Microbiome Drugs Development Status and Outlook
    6.1 EU Microbiome Drugs Market Size (2012-2017)
    6.2 EU Microbiome Drugs Market Size and Market Share by Players (2016 and 2017)

7 Japan Microbiome Drugs Development Status and Outlook
    7.1 Japan Microbiome Drugs Market Size (2012-2017)
    7.2 Japan Microbiome Drugs Market Size and Market Share by Players (2016 and 2017)

8 China Microbiome Drugs Development Status and Outlook
    8.1 China Microbiome Drugs Market Size (2012-2017)
    8.2 China Microbiome Drugs Market Size and Market Share by Players (2016 and 2017)

9 India Microbiome Drugs Development Status and Outlook
    9.1 India Microbiome Drugs Market Size (2012-2017)
    9.2 India Microbiome Drugs Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Microbiome Drugs Development Status and Outlook
    10.1 Southeast Asia Microbiome Drugs Market Size (2012-2017)
    10.2 Southeast Asia Microbiome Drugs Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
    11.1 Global Microbiome Drugs Market Size (Value) by Regions (2017-2022)
        11.1.1 United States Microbiome Drugs Revenue and Growth Rate (2017-2022)
        11.1.2 EU Microbiome Drugs Revenue and Growth Rate (2017-2022)
        11.1.3 Japan Microbiome Drugs Revenue and Growth Rate (2017-2022)
        11.1.4 China Microbiome Drugs Revenue and Growth Rate (2017-2022)
        11.1.5 India Microbiome Drugs Revenue and Growth Rate (2017-2022)
        11.1.6 Southeast Asia Microbiome Drugs Revenue and Growth Rate (2017-2022)
    11.2 Global Microbiome Drugs Market Size (Value) by Type (2017-2022)
    11.3 Global Microbiome Drugs Market Size by Application (2017-2022)

12 Microbiome Drugs Market Dynamics
    12.1 Microbiome Drugs Market Opportunities
    12.2 Microbiome Drugs Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Microbiome Drugs Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Microbiome Drugs Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source

List of Tables and Figures

    Figure Microbiome Drugs Product Scope
    Figure Global Microbiome Drugs Market Size (Million USD) (2012-2017)
    Table Global Microbiome Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Global Microbiome Drugs Market Share by Regions in 2016
    Figure United States Microbiome Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure EU Microbiome Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Japan Microbiome Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure China Microbiome Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure India Microbiome Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Southeast Asia Microbiome Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Global Microbiome Drugs Market Share by Type in 2016
    Figure Probiotics Market Size (Million USD) and Growth Rate (2012-2017)
    Figure Prebiotics Market Size (Million USD) and Growth Rate (2012-2017)
    Figure Small Molecules Market Size (Million USD) and Growth Rate (2012-2017)
    Figure Biological Drugs Market Size (Million USD) and Growth Rate (2012-2017)
    Figure Other Market Size (Million USD) and Growth Rate (2012-2017)
    Figure Global Microbiome Drugs Market Share by Application in 2016
    Table Key Downstream Customer in Hospital Pharmacies
    Figure Microbiome Drugs Market Size (Million USD) and Growth Rate in Hospital Pharmacies (2012-2017)
    Table Key Downstream Customer in Retail Pharmacies
    Figure Microbiome Drugs Market Size (Million USD) and Growth Rate in Retail Pharmacies (2012-2017)
    Table Key Downstream Customer in Online Pharmacies
    Figure Microbiome Drugs Market Size (Million USD) and Growth Rate in Online Pharmacies (2012-2017)
    Table Key Downstream Customer in Other
    Figure Microbiome Drugs Market Size (Million USD) and Growth Rate in Other (2012-2017)
    Table Microbiome Drugs Market Size (Million USD) by Players (2016 and 2017)
    Figure Microbiome Drugs Market Size Share by Players in 2016
    Figure Microbiome Drugs Market Size Share by Players in 2017
    Table Pfizer Basic Information List
    Table Microbiome Drugs Business Revenue (Million USD) of Pfizer (2012-2017)
    Figure Pfizer Microbiome Drugs Business Revenue Market Share in 2016
    Table Second Genome Basic Information List
    Table Microbiome Drugs Business Revenue (Million USD) of Second Genome (2012-2017)
    Figure Second Genome Microbiome Drugs Business Revenue Market Share in 2016
    Table Seres Therapeutics Basic Information List
    Table Microbiome Drugs Business Revenue (Million USD) of Seres Therapeutics (2012-2017)
    Figure Seres Therapeutics Microbiome Drugs Business Revenue Market Share in 2016
    Table MaaT Pharma Basic Information List
    Table Microbiome Drugs Business Revenue (Million USD) of MaaT Pharma (2012-2017)
    Figure MaaT Pharma Microbiome Drugs Business Revenue Market Share in 2016
    Table Enterome Bioscience Basic Information List
    Table Microbiome Drugs Business Revenue (Million USD) of Enterome Bioscience (2012-2017)
    Figure Enterome Bioscience Microbiome Drugs Business Revenue Market Share in 2016
    Table MicroBiome Therapeutics Basic Information List
    Table Microbiome Drugs Business Revenue (Million USD) of MicroBiome Therapeutics (2012-2017)
    Figure MicroBiome Therapeutics Microbiome Drugs Business Revenue Market Share in 2016
    Table Ritter Pharmaceuticals Basic Information List
    Table Microbiome Drugs Business Revenue (Million USD) of Ritter Pharmaceuticals (2012-2017)
    Figure Ritter Pharmaceuticals Microbiome Drugs Business Revenue Market Share in 2016
    Table Rebiotix Basic Information List
    Table Microbiome Drugs Business Revenue (Million USD) of Rebiotix (2012-2017)
    Figure Rebiotix Microbiome Drugs Business Revenue Market Share in 2016
    Table OpenBiome Basic Information List
    Table Microbiome Drugs Business Revenue (Million USD) of OpenBiome (2012-2017)
    Figure OpenBiome Microbiome Drugs Business Revenue Market Share in 2016
    Table Global Microbiome Drugs Market Size (Million USD) by Type (2012-2017)
    Figure Global Microbiome Drugs Market Size Share by Type in 2012
    Figure Global Microbiome Drugs Market Size Share by Type in 2013
    Figure Global Microbiome Drugs Market Size Share by Type in 2014
    Figure Global Microbiome Drugs Market Size Share by Type in 2015
    Figure Global Microbiome Drugs Market Size Share by Type in 2016
    Figure Global Microbiome Drugs Market Size Share by Type in 2017
    Table Global Microbiome Drugs Market Size (Million USD) by Application (2012-2017)
    Figure Global Microbiome Drugs Market Size (Million USD) by Application in 2012
    Figure Global Microbiome Drugs Market Size (Million USD) by Application in 2013
    Figure Global Microbiome Drugs Market Size (Million USD) by Application in 2014
    Figure Global Microbiome Drugs Market Size (Million USD) by Application in 2015
    Figure Global Microbiome Drugs Market Size (Million USD) by Application in 2016
    Figure Global Microbiome Drugs Market Size (Million USD) by Application in 2017
    Table Top Consumer/End Users of Microbiome Drugs
    Figure United States Microbiome Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table United States Microbiome Drugs Market Size (Million USD) by Players (2012-2017)
    Figure United States Microbiome Drugs Market Size Share by Players in 2016
    Figure United States Microbiome Drugs Market Size Share by Players in 2017
    Figure EU Microbiome Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table EU Microbiome Drugs Market Size (Million USD) by Players (2012-2017)
    Figure EU Microbiome Drugs Market Size Share by Players in 2016
    Figure EU Microbiome Drugs Market Size Share by Players in 2017
    Figure Japan Microbiome Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table Japan Microbiome Drugs Market Size (Million USD) by Players (2012-2017)
    Figure Japan Microbiome Drugs Market Size Share by Players in 2016
    Figure Japan Microbiome Drugs Market Size Share by Players in 2017
    Figure China Microbiome Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table China Microbiome Drugs Market Size (Million USD) by Players (2012-2017)
    Figure China Microbiome Drugs Market Size Share by Players in 2016
    Figure China Microbiome Drugs Market Size Share by Players in 2017
    Figure India Microbiome Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table India Microbiome Drugs Market Size (Million USD) by Players (2012-2017)
    Figure India Microbiome Drugs Market Size Share by Players in 2016
    Figure India Microbiome Drugs Market Size Share by Players in 2017
    Figure Southeast Asia Microbiome Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table Southeast Asia Microbiome Drugs Market Size (Million USD) by Players (2012-2017)
    Figure Southeast Asia Microbiome Drugs Market Size Share by Players in 2016
    Figure Southeast Asia Microbiome Drugs Market Size Share by Players in 2017
    Figure Global Microbiome Drugs Market Size (Million USD) by Regions (2017-2022)
    Table Global Microbiome Drugs Market Size (Million USD) by Regions (2017-2022)
    Figure Global Microbiome Drugs Market Size Share by Regions in 2017
    Figure Global Microbiome Drugs Market Size Share by Regions in 2022
    Figure United States Microbiome Drugs Revenue (Million USD) and Growth Rate (2017-2022)
    Figure EU Microbiome Drugs Revenue (Million USD) and Growth Rate (2017-2022)
    Figure Japan Microbiome Drugs Revenue (Million USD) and Growth Rate (2017-2022)
    Figure China Microbiome Drugs Revenue (Million USD) and Growth Rate (2017-2022)
    Figure India Microbiome Drugs Revenue (Million USD) and Growth Rate (2017-2022)
    Figure Southeast Asia Microbiome Drugs Revenue (Million USD) and Growth Rate (2017-2022)
    Table Global Microbiome Drugs Market Size (Million USD) by Type (2017-2022)
    Figure Global Microbiome Drugs Market Size Share by Type in 2017
    Figure Global Microbiome Drugs Market Size Share by Type in 2022
    Table Global Microbiome Drugs Market Size (Million USD) by Application (2017-2022)
    Figure Global Microbiome Drugs Market Size (Million USD) by Application in 2017
    Figure Global Microbiome Drugs Market Size (Million USD) by Application in 2022